Using immunohistochemistry, they measured PKCε and amyloid-β (Aβ) levels in hippocampal neurons from postmortem AD brain samples and analyzed skin fibroblasts from AD patients, non-AD dementia patients, and healthy controls with ELISA. This evidence concerns the gene PRKCE and Alzheimer disease.